Skip to content

Effect of remimazolam on shivering and intraoperative traction response in neuraxial anesthesia cesarean section patients

Effect of Remimazolam on Shivering in Parturients Undergoing Cesarean Delivery with Intrathecal Anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105881
Enrollment
Unknown
Registered
2025-07-14
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shivering

Interventions

The remazolam group (group R) :After the fetus was removed from the umbilical cord clamping, group R (n=40) was given an intravenous injection of remazolam 0.1 mg/kg followed by a target-controlled in
the saline group (group C):After the fetus was removed from the umbilical cord clamping,group C (n = 40), equal doses of saline were infused during the same period.

Sponsors

The First Affiliated Hospital of Anhui University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 18 years; 2. ASA grade I to III; 3.body mass index (BMI) of 18 to 28 kg/m²; 4.singleton pregnant women scheduled for emergency cesarean section under spinal anesthesia; 5.willing to participate and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Axillary temperature > 37.0°C or = 180/110 mmHg); 3.contraindications for spinal anesthesia; 4.gestational age = 600 mL; 6.subjects allergic to the study drug; 7.anesthesia level did not reach T6 or was changed to general anesthesia.

Design outcomes

Primary

MeasureTime frame
he incidence and severity of chills ;

Secondary

MeasureTime frame
temperature; heart rate ;mean artery pressure;

Countries

China

Contacts

Public ContactMinghong Liu

The First Affiliated Hospital of Anhui University of Science and Technology

1449409590@qq.com+86 183 5545 1537

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026